Detection of M2-macrophages in uveal melanoma and relation with survival

Investigative Ophthalmology and Visual Science

Volumn 52, Issue 2, 2011, Pages 643-650

  Bronkhorst, Inge H G ^a   Ly, Long V ^a   Jordanova, Ekaterina S ^a   Vrolijk, Johannes ^a   Versluis, Mieke ^a   Luyten, Gregorius P M ^a   Jager, Martine J ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD163 ANTIBODY; CD163 ANTIGEN; CD68 ANTIBODY; CD68 ANTIGEN; MONOCLONAL ANTIBODY; UNCLASSIFIED DRUG; CD68 ANTIGEN, HUMAN; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; LEUKOCYTE ANTIGEN;

ADULT; AGED; ARTICLE; CANCER STAGING; CANCER SURVIVAL; CELL DENSITY; CELL INFILTRATION; CELLULAR DISTRIBUTION; CHROMOSOME 3; CLINICAL ARTICLE; CONFOCAL MICROSCOPY; CONTROLLED STUDY; FEMALE; HISTOCHEMISTRY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOFLUORESCENCE; M2 MACROPHAGE; MACROPHAGE; MALE; MONOSOMY; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; UVEA MELANOMA; CELL COUNT; CELL MOTION; FLUORESCENT ANTIBODY TECHNIQUE; GENETICS; IMMUNOPHENOTYPING; MELANOMA; METABOLISM; MIDDLE AGED; MORTALITY; PATHOLOGY; SURVIVAL RATE; UNIPARENTAL DISOMY; UVEA TUMOR;

ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL COUNT; CELL MOVEMENT; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOPHENOTYPING; MACROPHAGES; MALE; MELANOMA; MICROSCOPY, CONFOCAL; MIDDLE AGED; MONOSOMY; PHENOTYPE; PROGNOSIS; RECEPTORS, CELL SURFACE; SURVIVAL RATE; UNIPARENTAL DISOMY; UVEAL NEOPLASMS;

EID: 79953276590     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5979     Document Type: Article

References (38)

1. Bergman L, Seregard S, Nilsson B, Ringborg U, Lundell G, Rag-narsson-Olding B. Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci. 2002;43:2579-2583.
2. Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology. 2003;110:956-961.
3. Eskelin S, Pyrhonen S, Summanen P, Hahka-Kemppinen M, Kivela T. Tumor doubling times in metastatic malignant melanoma of the uvea: tumor progression before and after treatment. Ophthalmology. 2000;107:1443-1449.
4. Affeldt JC, Minckler DS, Azen SP, Yeh L. Prognosis in uveal melanoma with extrascleral extension. Arch Ophthalmol. 1980;98:1975-1979
5. Horsman DE, Sroka H, Rootman J, White VA. Monosomy 3 and isochromosome 8q in a uveal melanoma. Cancer Genet Cytogenet 1990;45:249-253.
6. Makitie T, Summanen P, Tarkkanen A, Kivela T. Tumor-infiltrating macrophages (CD68(+) cells) and prognosis in malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2001;42:1414-1421.
7. Schmittel A, Bechrakis NE, Martus P, et al. Independent prognostic factors for distant metastases and survival in patients with primary uveal melanoma. Eur J Cancer. 2004;40:2389-2395
8. Maat W, Ly LV, Jordanova ES, Wolff-Rouendaal D, Schalij-Delfos NE, Jager MJ. Monosomy of chromosome 3 and an inflammatory phenotype occur together in uveal melanoma. Invest Ophthalmol Vis Sci. 2008;49:505-510.
9. Gordon S. The macrophage. Bioessays. 1995;17:977-986.
10. Gabrilovich DI, Nagaraj S. Myeloid-derived suppressor cells as regulators of the immune system. Nat Rev Immunol. 2009;9:162-174.
11. Guruvayoorappan C. Tumor versus tumor-associated macrophages: how hot is the link? Integr Cancer Ther. 2008;7:90-95
12. Mantovani A, Sozzani S, Locati M, Allavena P, Sica A. Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol. 2002;23: 549-555.
13. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol. 2000;164:6166-6173.
14. Lau SK, Chu PG, Weiss LM. CD163: a specific marker of macrophages in paraffin-embedded tissue samples. Am J Clin Pathol. 2004;122:794-801.
15. Nguyen TT, Schwartz EJ, West RB, Warnke RA, Arber DA, Natku-nam Y. Expression of CD163 (hemoglobin scavenger receptor) in normal tissues, lymphomas, carcinomas, and sarcomas is largely restricted to the monocyte/macrophage lineage. Am J Surg Pathol. 2005;29:617-624.
16. Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy. Eur J Cancer. 2006;42:717-727.
17. Makitie T, Summanen P, Tarkkanen A, Kivela T. Microvascular density in predicting survival of patients with choroidal and ciliary body melanoma. Invest Ophthalmol Vis Sci. 1999;40:2471-2480.
18. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, Trotti A. eds. Malignant melanoma of the uvea. American Joint Committee on Cancer, Cancer Staging Manual. 7th ed. New York: London: Springer; 2010:547-560.
19. Finger PT. The 7th ed: AJCC staging system for eye cancer: an international language for ophthalmic oncology. Arch Pathol Lab Med. 2009;133:1197-1198.
20. Polak ME, Borthwick NJ, Johnson P, et al. Presence and phenotype of dendritic cells in uveal melanoma. Br J Ophthalmol. 2007;91: 971-976.
21. Pollard JW. Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev Cancer. 2004;4:71-78.
22. Jager MJ, Hurks HM, Levitskaya J, Kiessling R. HLA expression in uveal melanoma: there is no rule without some exception. Hum Immunol. 2002;63:444-451.
23. Jensen TO, Schmidt H, Moller HJ, et al. Macrophage markers in serum and tumor have prognostic impact in American Joint Committee on Cancer stage I/II melanoma. J Clin Oncol. 2009;27: 3330-3337.
24. Kawamura K, Komohara Y, Takaishi K, Katabuchi H, Takeya M. Detection of M2 macrophages and colony-stimulating factor 1 expression in serous and mucinous ovarian epithelial tumors. Pathol Int. 2009;59:300-305.
25. Kurahara H, Shinchi H, Mataki Y, et al. Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res. Published online June 26, 2009. DOI:10.1016/j.jss.2009.05.026.
26. Shabo I, Olsson H, Sun XF, Svanvik J. Expression of the macro-phage antigen CD163 in rectal cancer cells is associated with early local recurrence and reduced survival time. Int J Cancer. 2009; 125:1826-1831.
27. Shabo I, Stal O, Olsson H, Dore S, Svanvik J. Breast cancer expression of CD163, a macrophage scavenger receptor, is related to early distant recurrence and reduced patient survival. Int J Cancer. 2008;123:780-786.
28. Ohri CM, Shikotra A, Green RH, Waller DA, Bradding P. Macro-phages within NSCLC tumour islets are predominantly of a cyto-toxic M1 phenotype associated with extended survival. Eur Resp J. 2009;33:118-126.
29. Nagorsen D, Voigt S, Berg E, Stein H, Thiel E, Loddenkemper C. Tumor-infiltrating macrophages and dendritic cells in human colo-rectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival. J Transl Med. 2007;5:62.
30. Woodward J, Sisley K, Reeves G, et al. Evidence of macrophage and lymphocyte, but not dendritic cell, infiltration in posterior uveal melanomas, whilst cultured uveal melanomas demonstrate pluripotency by expressing CD68 and CD163. Int J Exp Pathol. 2004;85:35-43.
31. Folkman J. Role of angiogenesis in tumor growth and metastasis. Semin Oncol. 2002;29:15-18.
32. El Filali M, Missotten GS, Maat W, et al. Regulation of VEGF-A in uveal melanoma. Invest Ophthalmol Vis Sci. 2010;51:2329-2337.
33. Lin EY, Li JF, Gnatovskiy L, et al. Macrophages regulate the angio-genic switch in a mouse model of breast cancer. Cancer Res. 2006;66:11238-11246.
34. Niederkorn JY. Immune escape mechanisms of intraocular tumors. Prog Retin Eye Res. 2009;28:329-347.
35. Ly LV, Baghat A, Versluis M, et al. In aged mice, outgrowth of intraocular melanoma depends on pro-angiogenic M2-type macro-phages. J Immunol. 2010;185:3481-3488.
36. Buechler C, Ritter M, Orso E, Langmann T, Klucken J, Schmitz G. Regulation of scavenger receptor CD163 expression in human monocytes and macrophages by pro- and antiinflammatory stimuli. J Leukoc Biol. 2000;67:97-103.
37. Ly LV, Bronkhorst IH, van Beelen E, et al. Inflammatory cytokines in eyes with uveal melanoma and relation with macrophage infiltration. Invest Ophthalmol Vis Sci. 2010;51:5445-5451.
38. van Klink F, Taylor WM, Alizadeh H, Jager MJ, van Rooijen N, Niederkorn JY. The role of macrophages in Acanthamoeba kerati-tis. Invest Ophthalmol Vis Sci. 1996;37:1271-1281.